tirzepatide used for Dosing: Diabetes vs Weight Loss New Tirzepatide Access and Pricing

Answer : The driving factors of the GLP-1 market are the expanding clinical indication of these therapies, which are now evolving from handling Type 2 diabetes to long-term chronic weight management and even cardiovascular risk reduction

Here's what the science shows: In a clinical trial of adults with type 2 diabetes already taking metformin , people who added liraglutide 1.21.8 mg lost around 6 pounds after six months, compared with 3 pounds on placebo, on average

: - - - / / - / / / / / / / - /

Type 2 diabetes in adults: management (NG28) Reviewing medicines